Literature DB >> 1969843

Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics.

J L Serre1, B Simon-Bouy, E Mornet, B Jaume-Roig, A Balassopoulou, M Schwartz, A Taillandier, J Boué, A Boué.   

Abstract

The prenatal diagnosis of cystic fibrosis is now routinely performed by using two probes tightly linked to the CF locus (XV2C and KM19). These probes have been shown to exhibit a strong linkage disequilibrium with the CF locus. Our data (103 families) have been pooled with other French data (237 families). They are consistent with the hypothesis of a unique ancestral mutation initially associated with a B (D1E2) restriction fragment length polymorphism (RFLP) haplotype, subsequently reassociated by cross-over with A, C or D haplotypes. Assuming such an hypothesis, the mutation is supposed to be 3000-6000 years old, depending on generation length and the true recombination ratio between the KM19 and CF loci. Up-to-date Spanish, Danish and Greek data are reported together with other previously published population data in order to discuss the geographic origin and age of the mutation in Europe. The action of selection in terms of heterozygote advantage and distorsion of segregation is discussed.

Entities:  

Mesh:

Year:  1990        PMID: 1969843     DOI: 10.1007/bf00195818

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Recombinations between IRP and cystic fibrosis.

Authors:  M Farrall; B J Wainwright; G L Feldman; A Beaudet; Z Sretenovic; D Halley; M Simon; L Dickerman; M Devoto; G Romeo
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

2.  Cystic fibrosis: typing 89 German families with linked DNA probes.

Authors:  J Weber; C Aulehla-Scholz; R Kaiser; A Eigel; M Neugebauer; J Horst; K Olek
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

3.  Further data supporting linkage between cystic fibrosis and the met oncogene and haplotype analysis with met and pJ3.11.

Authors:  M Farrall; E Watson; G Bates; G Bell; J Bell; K A Davies; X Estivill; H Kruyer; H Y Law; N Lench
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

4.  Genetic studies on cystic fibrosis in Hawaii.

Authors:  S W Wright; N E Morton
Journal:  Am J Hum Genet       Date:  1968-03       Impact factor: 11.025

5.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

6.  Linkage relationships and allelic associations of the cystic fibrosis locus and four marker loci.

Authors:  J Schmidtke; M Krawczak; M Schwartz; M Alkan; M Bonduelle; E Bühler; M Chemke; T Darnedde; J Domagk; W Engel
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

7.  Hypothesis: a selective advantage for cystic fibrosis heterozygotes.

Authors:  R S Meindl
Journal:  Am J Phys Anthropol       Date:  1987-09       Impact factor: 2.868

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Cystic fibrosis--a single locus disease? Results of a population genetics study.

Authors:  J Gedschold; S Kropf; R Szibor; M Berger
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

10.  Genetic differences between cystic fibrosis with and without meconium ileus.

Authors:  E Mornet; B Simon-Bouy; J L Serre; X Estivill; M Farrall; R Williamson; J Boue; A Boue
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

View more
  38 in total

1.  Allele age and a test for selection on rare alleles.

Authors:  M Slatkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-11-29       Impact factor: 6.237

2.  Bayesian fine-scale mapping of disease loci, by hidden Markov models.

Authors:  A P Morris; J C Whittaker; D J Balding
Journal:  Am J Hum Genet       Date:  2000-06-01       Impact factor: 11.025

3.  Can a place of origin of the main cystic fibrosis mutations be identified?

Authors:  Eva Mateu; Francesc Calafell; Maria Dolors Ramos; Teresa Casals; Jaume Bertranpetit
Journal:  Am J Hum Genet       Date:  2001-11-16       Impact factor: 11.025

4.  Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies.

Authors:  A P Morris; J C Whittaker; D J Balding
Journal:  Am J Hum Genet       Date:  2002-02-08       Impact factor: 11.025

5.  Short tandem-repeat polymorphism/alu haplotype variation at the PLAT locus: implications for modern human origins.

Authors:  S A Tishkoff; A J Pakstis; M Stoneking; J R Kidd; G Destro-Bisol; A Sanjantila; R B Lu; A S Deinard; G Sirugo; T Jenkins; K K Kidd; A G Clark
Journal:  Am J Hum Genet       Date:  2000-09-13       Impact factor: 11.025

6.  Frequency of delta F508 mutation and haplotype analysis in Austrian cystic fibrosis families.

Authors:  J Larsen; A Georghiou; F D Kury; M Götz; K Sanz; K Dobianer; J Spona
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

7.  A method for detecting recent selection in the human genome from allele age estimates.

Authors:  Christopher Toomajian; Richard S Ajioka; Lynn B Jorde; James P Kushner; Martin Kreitman
Journal:  Genetics       Date:  2003-09       Impact factor: 4.562

8.  Bayesian association-based fine mapping in small chromosomal segments.

Authors:  Mikko J Sillanpää; Madhuchhanda Bhattacharjee
Journal:  Genetics       Date:  2004-09-15       Impact factor: 4.562

9.  Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. European Working Group on CF Genetics (EWGCFG).

Authors: 
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

Review 10.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.